TY - JOUR AU - Kang, D. AU - Feng, D. AU - Ginex, T. AU - Zou, J. AU - Wei, F. AU - Zhao, T. AU - Huang, B. AU - Sun, Y. AU - Desta, S. AU - Clercq, E. PY - 2020 DA - 2020// TI - Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs JO - Acta Pharm Sin B VL - 10 UR - https://doi.org/10.1016/j.apsb.2019.08.013 DO - 10.1016/j.apsb.2019.08.013 ID - Kang2020 ER - TY - JOUR AU - Wu, Y. AU - Tang, C. AU - Rui, R. AU - Yang, L. AU - Ding, W. AU - Wang, J. AU - Li, Y. AU - Lai, C. C. AU - Wang, Y. AU - Luo, R. PY - 2020 DA - 2020// TI - Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors JO - Acta Pharm Sin B VL - 10 UR - https://doi.org/10.1016/j.apsb.2019.08.009 DO - 10.1016/j.apsb.2019.08.009 ID - Wu2020 ER - TY - JOUR AU - Zhan, P. AU - Chen, X. AU - Li, D. AU - Fang, Z. AU - Clercq, E. AU - Liu, X. PY - 2013 DA - 2013// TI - HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design JO - Med Res Rev VL - 33 UR - https://doi.org/10.1002/med.20241 DO - 10.1002/med.20241 ID - Zhan2013 ER - TY - JOUR AU - Zhan, P. AU - Pannecouque, C. AU - Clercq, E. AU - Liu, X. PY - 2016 DA - 2016// TI - Anti-HIV drug discovery and development: current innovations and future trends JO - J Med Chem VL - 59 UR - https://doi.org/10.1021/acs.jmedchem.5b00497 DO - 10.1021/acs.jmedchem.5b00497 ID - Zhan2016 ER - TY - JOUR AU - Das, K. AU - Arnold, E. PY - 2013 DA - 2013// TI - HIV-1 reverse transcriptase and antiviral drug resistance. Part 2 JO - Curr Opin Virol VL - 3 UR - https://doi.org/10.1016/j.coviro.2013.03.014 DO - 10.1016/j.coviro.2013.03.014 ID - Das2013 ER - TY - JOUR AU - Sluis-Cremer, N. PY - 2018 DA - 2018// TI - Future of non-nucleoside reverse transcriptase inhibitors JO - Proc Natl Acad Sci USA. VL - 115 UR - https://doi.org/10.1073/pnas.1720975115 DO - 10.1073/pnas.1720975115 ID - Sluis-Cremer2018 ER - TY - JOUR AU - Kang, D. AU - Wang, Z. AU - Zhang, H. AU - Wu, G. AU - Zhao, T. AU - Zhou, Z. AU - Huo, Z. AU - Huang, B. AU - Feng, D. AU - Ding, X. PY - 2018 DA - 2018// TI - Further exploring solvent-exposed tolerant regions of allosteric binding pocket for novel HIV-1 NNRTIs discovery JO - ACS Med Chem Lett VL - 9 UR - https://doi.org/10.1021/acsmedchemlett.8b00054 DO - 10.1021/acsmedchemlett.8b00054 ID - Kang2018 ER - TY - JOUR AU - Lansdon, E. B. AU - Brendza, K. M. AU - Hung, M. AU - Wang, R. AU - Mukund, S. AU - Jin, D. AU - Birkus, G. AU - Kutty, N. AU - Liu, X. PY - 2010 DA - 2010// TI - Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design JO - J Med Chem VL - 53 UR - https://doi.org/10.1021/jm1002233 DO - 10.1021/jm1002233 ID - Lansdon2010 ER - TY - JOUR AU - Sharma, M. AU - Saravolatz, L. D. PY - 2013 DA - 2013// TI - Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor JO - J Antimicrob Chemother VL - 68 UR - https://doi.org/10.1093/jac/dks404 DO - 10.1093/jac/dks404 ID - Sharma2013 ER - TY - JOUR AU - Das, K. AU - Bauman, J. D. AU - Clark, A. D. AU - Frenkel, Y. V. AU - Lewi, P. J. AU - Shatkin, A. J. AU - Hughes, S. H. AU - Arnold, E. PY - 2008 DA - 2008// TI - High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations JO - Proc Natl Acad Sci U S A. VL - 105 UR - https://doi.org/10.1073/pnas.0711209105 DO - 10.1073/pnas.0711209105 ID - Das2008 ER - TY - STD TI - Guillemont JEG, Palandjian P, De Jonge MR, Koymans LMH, Vinkers HM, Daeyaert FFD, Heeres J, Van Aken KJA, Lewi PJ, Janssen PAJ (2003) WO 03016306 Feb 2003 ID - ref11 ER - TY - STD TI - Guillemont JEG, Stevens PTA, Copmans AH, Peeters J, Stappers AE, Vandecruys RPG, Stoffels P (2006) US 20060111379 A1 May 2006 ID - ref12 ER - TY - JOUR AU - Schils, D. AU - Stappers, F. AU - Solberghe, G. PY - 2008 DA - 2008// TI - Ligandless Heck coupling between a halogenated aniline and acrylonitrile catalyzed by Pd/C: development and optimization of an industrial-scale Heck process for the production of a pharmaceutical intermediate JO - Org Process Res Dev VL - 12 UR - https://doi.org/10.1021/op8000383 DO - 10.1021/op8000383 ID - Schils2008 ER - TY - STD TI - Reddy BP, Reddy KR, Reddy DM, Reddy AVN, Krishna BV. (2012) WO 2012147091 Nov2012 ID - ref14 ER - TY - JOUR AU - Spychala, J. PY - 1997 DA - 1997// TI - A facile preparation of N2-arylisocytosines JO - Synth Commun VL - 27 UR - https://doi.org/10.1080/00397919708006796 DO - 10.1080/00397919708006796 ID - Spychala1997 ER - TY - JOUR AU - Gu, S. X. AU - Yang, S. Q. AU - He, Q. Q. AU - Ma, X. D. AU - Chen, F. E. AU - Dai, H. F. AU - Clercq, E. D. AU - Balzarini, J. AU - Pannecouque, C. PY - 2011 DA - 2011// TI - Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs JO - Bioorg Med Chem VL - 19 UR - https://doi.org/10.1016/j.bmc.2011.10.002 DO - 10.1016/j.bmc.2011.10.002 ID - Gu2011 ER - TY - JOUR AU - Zhou, Z. AU - Liu, T. AU - Wu, G. AU - Kang, D. AU - Fu, Z. AU - Wang, Z. AU - Clercq, E. AU - Pannecouque, C. AU - Zhan, P. AU - Liu, X. PY - 2019 DA - 2019// TI - Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus JO - Org Biomol Chem VL - 17 UR - https://doi.org/10.1039/C9OB00032A DO - 10.1039/C9OB00032A ID - Zhou2019 ER - TY - STD TI - Schils DPR, Stappers AE (2006) WO 2006125809 Nov 2006 ID - ref18 ER - TY - STD TI - Schils DPR, Willems JJM, Medaer BPAMJ, Pasquier ETJ, Janssen PAJ, Heeres J, Leenders RGG (2004) WO 2004016581 Feb 2004 ID - ref19 ER - TY - STD TI - Hajicek J, Slavikova M, Zebula J (2016) WO 2016116074 (A1) Jul 2016 ID - ref20 ER -